As filed with the Securities and Exchange Commission on April 2, 2026
Registration No. 333-
UNITED STATES
SECURITIES AND EXCHANGE COMMISSION
WASHINGTON, D.C. 20549
FORM S-8
REGISTRATION STATEMENT
UNDER
THE SECURITIES ACT OF 1933
|
Autonomix Medical, Inc. |
|
(Exact name of registrant as specified in its charter) |
|
Delaware |
47-1607810 |
|
|
(State or other jurisdiction of incorporation or organization) |
(I.R.S. Employer Identification Number) |
|
|
21 Waterway Avenue, Suite 300 The Woodlands, Texas |
77380 |
|
|
(Address of Principal Executive Offices) |
(Zip Code) |
Autonomix Medical, Inc. 2023 Stock Plan
(Full title of the plans)
Brad Hauser
Chief Executive Officer
21 Waterway Avenue, Suite 300
The Woodlands, Texas 77380
(713) 588-6150
(Name, address, including zip code, and telephone number,
including area code, of agent for service)
Copies to:
Cavas S. Pavri, Esq.
ArentFox Schiff LLP
1717 K Street, NW
Washington, DC 20006
(202) 724-6847
Facsimile: (202) 778-6460
Indicate by check mark whether the registrant is a large accelerated filer, an accelerated filer, a non-accelerated filer, a smaller reporting company or an emerging growth company. See the definitions of “large accelerated filer,” “accelerated filer,” “smaller reporting company,” and “emerging growth company” in Rule 12b-2 of the Securities Exchange Act of 1934. (Check one):
|
Large accelerated filer |
☐ |
Accelerated filer |
☐ |
|
Non-accelerated filer |
☒ |
Smaller reporting company |
☒ |
|
Emerging growth company |
☒ |
If an emerging growth company, indicate by check mark if the registrant has elected not to use the extended transition period for complying with any new or revised financial accounting standards provided to Section 7(a)(2)(B) of the Securities Act. ☐
PART I
INFORMATION REQUIRED PURSUANT
TO GENERAL INSTRUCTION E TO FORM S-8
This Registration Statement is being filed for the purpose of increasing the number of securities of the same class as other securities for which a Registration Statement of Autonomix Medical, Inc. (the “Registrant”) on Form S-8 relating to the same employee benefit plan is effective. This Registration Statement registers an additional 2,595,319 shares of common stock of the Registrant to be issued pursuant to the Registrant’s 2023 Stock Plan, as amended (the “Equity Plan”), which includes (i) 1,900,000 shares of common stock approved at the Registrant’s 2025 annual meeting of stockholders, and (ii) 695,319 shares of common stock pursuant to the “evergreen” provision of the Equity Plan. The contents of the previous Registration Statement on Form S-8 filed by us with the Securities and Exchange Commission for the Equity Plan on May 31, 2024 (file no. 333-279894), including any amendments thereto, are incorporated by reference into this Registration Statement pursuant to General Instruction E of Form S-8.
PART II
INFORMATION REQUIRED IN THE REGISTRATION STATEMENT
Item 3. Incorporation of Documents by Reference.
The Registrant hereby incorporates by reference in this Registration Statement the following documents and information previously filed with the Securities and Exchange Commission:
|
(a) |
|
(c) |
The Registrant’s Current Reports of Form 8-K filed on July 22, 2025; August 26, 2025; August 27, 2025; November 3, 2025; November 19, 2025; and January 16, 2026; |
|
(d) |
The Registrant’s Definitive Proxy Statement on Schedule 14A filed on September 12, 2025; and |
(e) The description of the Registrant’s common stock, par value $0.001 per share contained in its Registration Statement on Form 8-A, dated and filed with the SEC on January 26, 2024, and any amendment, exhibit to our Annual Report on Form 10-K or report filed with the SEC for the purpose of updating the description.
All documents filed by the Registrant pursuant to Sections 13(a), 13(c), 14 and 15(d) of the Securities Exchange Act of 1934, as amended (the “Exchange Act”), other than current reports furnished under Item 2.02 or Item 7.01 of Form 8-K and exhibits furnished on such form that relate to such items, subsequent to the date hereof and prior to the filing of a post-effective amendment that indicates that all securities offered have been sold or that deregisters all securities then remaining unsold shall also be deemed to be incorporated by reference herein and to be a part hereof from the dates of filing of such documents.
Any statement contained in a document incorporated or deemed to be incorporated by reference herein shall be deemed to be modified or superseded for purposes of this Registration Statement to the extent that a statement contained herein or in any other subsequently filed document which also is or is deemed to be incorporated by reference herein modifies or supersedes such statement. Any statement so modified or superseded shall not be deemed, except as so modified or superseded, to constitute a part of this Registration Statement.
Item 8. Exhibits.
|
Exhibit Number |
Description |
|
|
4.1 |
||
|
4.2 |
||
|
4.3 |
||
|
4.4* |
Autonomix Medical, Inc. 2023 Stock Plan, as amended and restated and forms of award agreements |
|
|
5.1* |
||
|
23.1* |
||
|
23.2* |
||
|
24.1* |
||
|
107* |
* Filed herewith
SIGNATURES
Pursuant to the requirements of the Securities Act of 1933, the registrant certifies that it has reasonable grounds to believe that it meets all of the requirements for filing on Form S-8 and has duly caused this registration statement to be signed on its behalf by the undersigned, thereunto duly authorized, in the city of The Woodlands, Texas, on April 2, 2026.
|
Autonomix Medical, Inc. |
|||
|
(Registrant) |
|||
|
By: |
/s/ Brad Hauser |
||
|
Brad Hauser |
|||
|
Chief Executive Officer |
|||
KNOW ALL PERSONS BY THESE PRESENTS, that each person whose signature appears below hereby constitutes and appoints Brad Hauser or Trent Smith as attorney-in-fact and agent, with full power of substitution and re-substitution, to sign on his or her behalf, individually and in any and all capacities, including the capacities stated below, any and all amendments (including post-effective amendments) to this Registration Statement, and to file the same, with all exhibits thereto, and other documents in connection therewith, with the Securities and Exchange Commission, granting to said attorney-in-fact and agent, full power and authority to do and perform each and every act and thing requisite and necessary to be done in and about the premises, as fully to all intents and purposes as he or she might or could do in person, hereby ratifying and confirming all that said attorney-in-fact and agent, or his substitute, may lawfully do or cause to be done by virtue hereof.
Pursuant to the requirements of the Securities Act of 1933, as amended, this registration statement has been signed below by the following persons in the capacities and on the dates indicated:
|
SIGNATURE |
TITLE |
DATE |
||
|
/s/ Brad Hauser |
Chief Executive Officer and Director |
|||
|
Brad Hauser |
(Principal Executive Officer) |
April 2, 2026 |
||
|
/s/ Trent Smith |
Chief Financial Officer |
|||
|
Trent Smith |
(Principal Financial Officer and Principal Accounting Officer) |
April 2, 2026 |
||
|
/s/ Walter V. Klemp |
||||
|
Walter V. Klemp |
Director |
April 2, 2026 |
||
|
/s/ Lori Bisson |
||||
|
Lori Bisson |
Director |
April 2, 2026 |
||
|
/s/ Jonathan P. Foster |
||||
|
Jonathan P. Foster |
Director |
April 2, 2026 |
||
|
/s/ David Robins |
||||
|
David Robins |
Director |
April 2, 2026 |
||
|
/s/ Christopher Capelli |
||||
|
Christopher Capelli |
Director |
April 2, 2026 |